Hogan Lovells has advised Novocure. Novocure has obtained U.S. Food and Drug Administration (FDA) approval for Optune Pax®, a portable, non-invasive medical device intended for the...
Novocure Receives FDA Approval for Optune Pax Device for Pancreatic Cancer Treatment
Bazzelle, Sr. v. NovoCure Limited et al
Sidley Austin assisted NovoCure Limited in the matter. In January 2023, NovoCure announced positive top-line results from a pivotal lung cancer trial. However, after presenting full...


























